Results shown below
On 6 August, we will be launching a tender to commission the creation of a new, open-access resource enabling community participation and co-production with Black, Asian, and minoritised ethnic patients, communities, and staff.
Teaching curricula widely studied by healthcare professionals working across the NHS are under review in an effort to improve patient care and reduce racialised health disparities.
Responding to the future elective recovery plan, Sam Rodger, Assistant Director, Policy and Strategy of the NHS Race and Health Observatory, said:
Pharmacogenomics is the study of how genetic variation affects responses to drugs. This includes both the efficacy and safety of drugs.
The COVID-19 pandemic has impacted all of us. Millions across the country have acquired or been diagnosed with the infection, with thousands suffering its debilitating medium and long-term effects.
Familial hypercholesterolemia is a disorder that is typically inherited from a parent causing high cholesterol levels. Without treatment, it can cause early heart attacks along with a higher risk of heart disease.
A recent parliamentary inquiry into avoidable deaths and failures of care for sickle cell patients in secondary care identified that too often acute painful sickle episodes are poorly managed by the NHS. It recommended that the NHS Race and Health Observatory (NHSRHO) undertake a study into sickle cell care in relation to race and ethnicity.
A recent parliamentary inquiry into avoidable deaths and failures of care for sickle cell patients in secondary care identified inadequate investment in sickle cell care. It recommended that the NHS Race and Health Observatory (NHSRHO) undertake a study into sickle cell care in relation to race and ethnicity.
Jewish communities in England experience health inequalities across a number of metrics including COVID-19 morbidity, immunisation take up, and breast cancer risk. The Jewish community has twice the number of people aged over 60 compared to the general population
At the frontier of medical innovation, technologies promise to make healthcare more personalised, more efficient, and safer.
